Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its availability have become key issues for patients and healthcare practitioners. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant challenge to many